Skip to main content

Closed

STRO: Sutro Biopharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-115.5%

ROIC-64.3%

Financially safe

Stretched

Debt / equity-0.20×

Interest coverage-2.9×

Current ratio3.12×

Sutro Biopharma, Inc.

STRONASDAQ Global Market·USD·Closed

Sutro Biopharma, Inc.

STRONASDAQ·USD·Closed

$24.17

−2.62%

$24.17

−$0.65 (2.62%)

52W Range

46thpctl

Volume

0.46×avg

Mkt Cap

233.90MUSD

P/E

-1.5TTM

Div Yield

–ann

52W Range

46thpctl

Volume

0.46×avg

Market Cap

233.90MUSD

P/E Ratio

-1.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings